1982Molecular mechanisms of arrhythmia upon TBX5 loss
نویسندگان
چکیده
منابع مشابه
Molecular Mechanisms of Recurrent Pregnancy Loss
Introduction: Pregnancy and health is the process in which the egg is fertilized and being able to survive. When pregnancy occurs under some conditions and the fetus is being at risk, it will lead to abortion that occurs involuntarily and spontaneously. Abortions that occur more than two or three times are called recurrent pregnancy loss (RPL). Various etiological factors involved in RPL, inclu...
متن کامل1768 Loss of Stem Cell Function Upon
The earliest precursor cell or stem cell that populates the immunohemopoiet ic system in mammals must have a high proliferative potential. Stem cells can be transplanted by intravenous injections of single cell suspensions and can repopulate stem cell-depleted recipients (1, 2). Therefore, stem cells have been used to test the hypothesis that mammal ian aging is genetically programmed to cause ...
متن کامل[Fe4S4] Core Aggregation upon Loss of Phosphine
The influence of tertiary phosphines on the stability of FeS3P coordination units and the formation of iron-sulfur clusters has been investigated. Reaction of [Fe4S4Cl4] with a small excess of PR3 in acetonitrile/THF affords the cubane-type clusters [Fe4S4(PR3)4] (R ) Cy, But, Pri), one-electron reduced over the initial cluster and possessing an S ) /2 ground state. These clusters may be electr...
متن کاملToward a hierarchy of mechanisms in CaMKII-mediated arrhythmia
Calcium/calmodulin-dependent protein kinase II (CaMKII) activity has been shown to contribute to arrhythmogenesis in a remarkably broad range of cardiac pathologies. Several of these involve significant structural and electrophysiologic remodeling, whereas others are due to specific channelopathies, and are not typically associated with arrhythmogenic changes to protein expression or cellular a...
متن کاملSpecies-Dependent Mechanisms of Cardiac Arrhythmia: A Cellular Focus
Although ventricular arrhythmia remains a leading cause of morbidity and mortality, available antiarrhythmic drugs have limited efficacy. Disappointing progress in the development of novel, clinically relevant antiarrhythmic agents may partly be attributed to discrepancies between humans and animal models used in preclinical testing. However, such differences are at present difficult to predict...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2017
ISSN: 0195-668X,1522-9645
DOI: 10.1093/eurheartj/ehx502.1982